What Researchers Did
Researchers retrospectively analyzed outcomes of hyperbaric oxygen treatment (HBOT) in 50 breasts with mastectomy flap ischaemia to evaluate its effectiveness in a case series.
What They Found
Hyperbaric oxygen treatment (HBOT) was initiated a median of 3 days post-surgery for a median of 12 sessions. The breast skin surface area scores improved in 34% of observations, and 29 breasts (58%) recovered without additional surgery. Pre-operative radiotherapy (OR 7.2) and postoperative infection (OR 15.4) were identified as significant risk factors for re-operation.
Canadian Relevance
This study does not have a direct Canadian connection as it was conducted outside of Canada.
Study Limitations
A key limitation of this study is its retrospective case series design, which limits the ability to establish causality and control for confounding factors.